Characteristics and Prognostic Markers of Aggressive Subtypes of Thyroid Cancer: A Retrospective Study
Cancer Reports · 2025
DOI: 10.1002/cnr2.70131 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Reports, 2025. Verfasst von Suhaib Radi und 5 weiteren Autor:innen. Beteiligte Einrichtung: College of Medicine, King Saud Bin Abdulaziz University for Health Sciences, Jeddah, Saudi Arabia. Hauptthemen laut MEDLINE: Thyroid Neoplasms, Biomarkers, Tumor, Thyroid Cancer, Papillary, Adenocarcinoma, Follicular. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objective
The prevalence of thyroid cancer has increased significantly. Aggressive subtypes of papillary thyroid cancer (AG‐PTC) and high‐grade follicular cell‐derived malignancies (HGFM) are malignancies that lie between well‐differentiated and undifferentiated cancers, and their management needs to be clarified. The aim of our study is to describe the clinicopathological characteristics of AG‐PTC and HGFM and to assess their prognostic value.
Methods
This was a retrospective chart review study at single center of patients with AG‐PTC or HGFM. HGFM comprised of patients with poorly differentiated thyroid cancer (PDTC) and differentiated high‐grade thyroid carcinoma. The clinical presentation, pathological characteristics, molecular markers, specific treatments, and clinical outcomes were compared between the groups.
Results
Of the 3244 thyroid cancer charts reviewed, 136 met the criteria for AG‐PTC and HGFM. The mean age at diagnosis was 49 years, with a predominance of women. The median follow‐up duration was 3 years. The rate of persistent or recurrent disease was 40.3% in the AG‐PTC group and 29.3% in the HGFM group, 4.5% died in the AG‐PTC group, and 1.8% died in the HGFM group. The presence of vascular, lymphovascular invasion and extrathyroidal extension were associated with a higher incidence of persistent or recurrent disease (Hazard ratio: 2.5, 3.8, and 4.2, respectively; p < 0.05). When the Ki‐67 index was divided into five groups, the recurrence rate was higher in the ≥ 20% Ki‐67 group.
Conclusions
Possible prognostic markers for predicting worse prognosis include vascular/lymphovascular invasion, extrathyroidal extension, and the proliferative index Ki‐67.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Medicine, King Saud Bin Abdulaziz University for Health Sciences, Jeddah, Saudi Arabia.
- King Abdullah International Medical Research Centre, Jeddah, Saudi Arabia.
- Department of Internal Medicine, Division of Endocrinology, Ministry of the National Guard-Health Affairs, Jeddah, Saudi Arabia.
- Division of Endocrinology and Metabolism, Jewish General Hospital, McGill University, Montreal, Quebec, Canada.
- Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia.
- Academic Unit of Medicine, Autonomous University of Nayarit, Tepic, Nayarit, Mexico.
ORCID-Profile: Suhaib Radi
Zitieren
APA
Radi, S., Al-Maghrabi, M., Binmahfooz, S., Franco, M., Payne, R., & Tamilia, M. (2025). Characteristics and Prognostic Markers of Aggressive Subtypes of Thyroid Cancer: A Retrospective Study. Cancer Reports. https://doi.org/10.1002/cnr2.70131
Vancouver
Radi S, Al-Maghrabi M, Binmahfooz S, Franco M, Payne R, Tamilia M. Characteristics and Prognostic Markers of Aggressive Subtypes of Thyroid Cancer: A Retrospective Study. Cancer Reports. 2025. doi:10.1002/cnr2.70131
BibTeX
@article{Radi2025,
author = {Radi, Suhaib and Al-Maghrabi, Mazin and Binmahfooz, Saleh and Franco, Miguel and Payne, Richard and Tamilia, Michael},
title = {Characteristics and Prognostic Markers of Aggressive Subtypes of Thyroid Cancer: A Retrospective Study},
journal = {Cancer Reports},
year = {2025},
doi = {10.1002/cnr2.70131}
}
EUVIMED